Some unconventional T cells and non-T cells, including NK, CD4+CD25+ or FoxP3+ Tregs, Th17 cells, γ-δT cells, and acrophages, have also been used in adoptive immunotherapy for cervical cancer. This evidence concerns the gene CD4 and cervical carcinoma.